Pharmaceutical

Merck KGaA abandons Phase III trial for $1.08bn head & ...

Merck’s decision follows the independent committee's analysis that the trial is ...

Oncoinvent’s Radspherin has FDA fast-track status for o...

Oncoinvent has received FDA fast track designation for its therapy, Radspherin, ...

Novavax seeks EMA approval for updated JN.1 Covid-19 va...

Novavax has sought EMA approval for its updated JN.1 Covid-19 vaccine, NVX-CoV27...

GSK’s Omjjara gains approval in Japan for myelofibrosis...

GSK has received approval from the Japan's Ministry of Health, Labour and Welfar...

Novo Nordisk invests $4.1bn in manufacturing facility i...

Novo Nordisk has unveiled a significant investment plan, committing $4.1bn to co...

Pharma packaging solutions, design and companies

Explore the critical aspects of pharma packaging solutions, design, and companie...

Magazine: UK’s new Netflix-style funding model for anti...

In this issue: UK’s new Netflix-style funding model for antibiotics, the Swiss b...

Pharma M&A: The top high value deals in 2023

From Pfizer’s Seagen acquisition to Sanofi’s deal with Provention Bio, Pharmaceu...

Medical packaging companies in pharmaceutical contract ...

Discover the critical factors in choosing medical packaging companies for pharma...

Sanofi and Biovac partner to produce polio vaccines in ...

Sanofi and Biovac have announced a partnership to establish the first African-ba...

AstraZeneca’s Truqap and Faslodex combo receives approv...

AstraZeneca has received approval for Truqap in combination with Faslodex in the...

Will WHO’s new guidance spur hepatitis B immunisation?

Based on the updated guidelines, over 50% of individuals with chronic hepatitis ...

EHA 2024: Monoclonal antibodies continue to dominate mu...

Trial investigators anticipate that the FDA will decide on approval for linvosel...

Sarepta’s Elevidys secures US label expansion for DMD

Sarepta’s stock rose by over 36% following the positive news of the FDA expandin...

Tectonic bets on GPCR heart failure drug following reve...

The company has also raised $130.7m in a private placement, which along with Tec...

WHO warns of “harmful” fake Ozempic in circulation in A...

Both Novo Nordisk and Eli Lilly have filed lawsuits against unapproved sellers o...